# Blue Forest Ventures

> Blue Forest Ventures is a VC fund backing Medical and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 1
- Last investment: Jul 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/blue-forest-ventures
- Website: https://www.blueforest.ventures

Blue Forest Ventures is a VC fund focused on Medical and Biotechnology. Blue Forest Ventures invests in deep technology start-ups in the pre-seed and seed stages.Blue Forest Ventures seeks to invest in firms that provide technical answers to hard scientific and engineering problems, thereby driving long-term transformation and advancement.

## Contacts

5 contacts available for Blue Forest Ventures. Shizune tracks 2 team members at Blue Forest Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/blue-forest-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Max Narr | Co-Founder & General Partner | 1 | — |
| Moises Gene | Co-Founder & General Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies that enable the rapid detection of DNA and RNA pathogens at the point of care. The company designs programmable diagnostic platforms that deliver laboratory-grade molecular testing without requiring specialized equipment or extensive technical training. Its technology uses syntheticbiology and portable diagnostic devices to support the detection of infectious diseases, including Lyme disease, as well as other bacterial and viral pathogens. En Carta Diagnostics also develops custom molecular diagnostic solutions and expands its platform to address a broad range of genetic and infectious disease applications. The company collaborates with research institutions and applies its proprietary diagnostic technology to improve the accessibility and reliability of molecular testing across healthcare settings. | $3.4M | Seed | Jul 10, 2026 |  |

1 of 1 investments shown.

## Co-investors
- [50 Partners Health](https://shizune.co/investors/profile/50-partners-health) — VC Fund, 1 deal together
- [CentraleSupélec Venture](https://shizune.co/investors/profile/centralesup%C3%A9lec-venture) — VC Fund, 1 deal together
- [Ring Capital](https://shizune.co/investors/profile/ring-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Blue Forest Ventures invest in?

Blue Forest Ventures invests primarily in Medical, Biotechnology and Health Diagnostics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Blue Forest Ventures?

Public channels for Blue Forest Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Blue Forest Ventures?

The team at Blue Forest Ventures includes Max Narr (Co-Founder & General Partner) and Moises Gene (Co-Founder & General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co